PUBLISHER: The Business Research Company | PRODUCT CODE: 1951663
PUBLISHER: The Business Research Company | PRODUCT CODE: 1951663
Cold and cough preparations are medications used to treat symptoms of cold and cough. These drugs work by targeting the receptors to which the virus attaches, antagonizing their action to eliminate the viral infection. This process helps reduce congestion by breaking down mucus and dilating the bronchioles that have been constricted due to mucus buildup.
The main types of drugs in cold and cough preparations include antihistamines, expectorants, bronchodilators, decongestants, antibiotics, and others. Antihistamines are compounds that block the physiological effects of histamine and are primarily used to treat allergies. Other types include bronchodilators, anticholinergics, and pulmonary antihypertensives. These medications are available in various dosage forms, such as oral syrups, tablets or pills, nasal drops, lozenges, and more, and are distributed through hospital pharmacies, retail pharmacies, and drug stores.
Tariffs have influenced the cough and cold preparations market by raising the cost of imported active pharmaceutical ingredients and packaging materials, impacting production and pricing across global markets. The segments most affected include oral syrups, tablets, and nasal drops, particularly in regions like Asia-Pacific and Europe where manufacturing and import dependencies are high. While costs have increased for manufacturers, tariffs have also encouraged local production and sourcing diversification, potentially accelerating innovation in drug formulations and cost-optimized solutions for consumers.
The cough and cold preparations market research report is one of a series of new reports from The Business Research Company that provides cough and cold preparations market statistics, including cough and cold preparations industry global market size, regional shares, competitors with a cough and cold preparations market share, detailed cough and cold preparations market segments, market trends and opportunities, and any further data you may need to thrive in the cough and cold preparations industry. This cough and cold preparations market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cough and cold preparations market size has grown steadily in recent years. It will grow from $88.07 billion in 2025 to $91.38 billion in 2026 at a compound annual growth rate (CAGR) of 3.8%. The growth in the historic period can be attributed to increasing prevalence of seasonal flu and common cold, growth in over-the-counter drug sales, rising awareness about respiratory health, expansion of retail pharmacy networks, availability of combination cold and cough medications.
The cough and cold preparations market size is expected to see steady growth in the next few years. It will grow to $109.88 billion in 2030 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to development of targeted antiviral drugs, adoption of personalized medicine approaches, integration of herbal and natural therapies, increasing demand for fast-acting symptom relief, expansion of online pharmacy channels. Major trends in the forecast period include novel antiviral formulations, personalized cold & cough therapies, herbal & natural remedies integration, combination drug therapies, rapid-acting symptomatic relief.
The rising incidence of allergies is expected to drive growth in the cough and cold preparations market over the forecast period. Respiratory allergies, such as those caused by pollen, dust, mold, and pets, result from contaminated indoor and outdoor air. Cough and cold preparations are commonly used to manage these allergies, which often trigger coughs and other respiratory issues. For example, the European Academy of Allergy and Clinical Immunology, a non-profit organization for European clinicians and researchers, projects that by 2025, 1 in every 3 people in the European Union will be affected by allergies. Consequently, the increasing prevalence of respiratory allergies is expected to boost demand for cough and cold preparations, positively influencing market growth.
The growing geriatric population is also expected to support the expansion of the cough and cold preparations market. The geriatric population refers to individuals aged 65 and older, who generally have weaker immune systems, making them more susceptible to respiratory infections like coughs and colds. This increased vulnerability drives greater demand for cough and cold remedies. For example, in January 2024, the Pew Research Center reported that the geriatric population is projected to increase by 0.5% by 2054. Therefore, the rising number of elderly individuals is contributing to the growth of the cough and cold preparations market.
Key players in the cough and cold preparations market are introducing new products, such as clean over-the-counter (OTC) medicines for children, to meet rising consumer demand for safer, natural, and effective remedies. Clean OTC kids' medicines are non-prescription formulations designed specifically for children, emphasizing natural ingredients and minimal additives. These products aim to relieve common cold and cough symptoms while avoiding harmful substances, appealing to parents seeking safer options. For instance, in September 2023, Genexa, a US-based pharmaceutical company, launched two clean OTC products: Kids' Multi-Symptom Cold and Flu, and the Kids Daytime Nighttime Cough Relief Value Pack. The Multi-Symptom Cold and Flu formulation temporarily controls cough, reduces fever, and alleviates minor aches without artificial ingredients. The Daytime and Nighttime Cough Relief Value Pack provides non-drowsy relief during the day and comfort at night, offering comprehensive symptom management for children.
Major companies operating in the cough and cold preparations market are Johnson & Johnson, GlaxoSmithKline plc, Procter & Gamble, Bayer AG, Reckitt Benckiser Group plc, Novartis AG, Perrigo Company, Sun Pharmaceutical Industries Ltd., Prestige Consumer Healthcare, Blackmores Limited, AFT Pharmaceuticals, Dexa Medica, Glenmark Pharmaceuticals Limited, Wockhardt Ltd, Apnar Pharma LP, Hanmi Pharmaceutical, Cipla Limited, Aurobindo Pharma Limited, KYORIN Holdings Inc, Nichi-Iko Pharmaceutical Co. Ltd, Otsuka Pharmaceutical Co. Ltd, China National Pharmaceutical Group Co. Ltd, Shanghai Anovent Pharma, Shanghai Acebright Pharmaceuticals Group Co. Ltd, China Meheco Group Co. Ltd, Merck & Co, Abbott Laboratories, Boehringer Ingelheim, Vectura Group, Pfizer, Mylan, Teva Pharmaceutical Industries Ltd, Sanofi, W. K. Buckley Limited, BENYLIN, Sanfer, PROBIOMED, PiSA, EMS Pharma, Hypermarcas, Ache, Eurofarma, Biolab Farmaceuticad, Cristalia, Libbs, AstraZeneca, Neopharma, Regal Pharmaceuticals, Adcock Ingram, Aspen Pharmacare
North America was the largest region in the cold and cough preparation market share in 2025. Middle East is expected to be the fastest-growing region in the global cough and cold preparations market during the forecast period. The regions covered in the cough and cold preparations market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cough and cold preparations market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cold and cough preparations market consists of sales of dextromethorphan, guaifenesin, and phenylephrine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cough And Cold Preparations Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cough and cold preparations market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cough and cold preparations ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cough and cold preparations market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.